DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway
Abstract Osteosarcoma (OS) is a frequently occurring bone malignancy with increased metastatic properties, causing deaths in large numbers around the world. Disulfiram (DSF) is clinically utilized to treat alcohol dependency and has been indicated to bind Cu(I) in-vivo to form DDTC-Cu(I), which has...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06748-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849334764528467968 |
|---|---|
| author | Ruhao Zhou Lei Yan Kun Zhang Song Chen Yang Yu Xiaochun Wei Yongchun Pan Chaojian Xu Xiaojuan Sun Zhi Lv Pengcui Li Xiaochen Qiao Yi Feng Zhi Tian |
| author_facet | Ruhao Zhou Lei Yan Kun Zhang Song Chen Yang Yu Xiaochun Wei Yongchun Pan Chaojian Xu Xiaojuan Sun Zhi Lv Pengcui Li Xiaochen Qiao Yi Feng Zhi Tian |
| author_sort | Ruhao Zhou |
| collection | DOAJ |
| description | Abstract Osteosarcoma (OS) is a frequently occurring bone malignancy with increased metastatic properties, causing deaths in large numbers around the world. Disulfiram (DSF) is clinically utilized to treat alcohol dependency and has been indicated to bind Cu(I) in-vivo to form DDTC-Cu(I), which has been confirmed for its antitumor effects. This investigation aimed to elucidate the efficacy of DDTC-Cu(I) on OS cell apoptosis, migration, growth, invasion, and underlying mechanisms. The in-vitro investigations were performed on U2OS, SaOS2, and MG-63 OS cell lines and included CCK-8, colony formation, RTCA, transwell invasion, flow cytometry, wound healing, and RNA seq assays. DDTC-Cu(I) was inoculated dose-dependent, increased apoptosis, and suppressed cells’ ability to proliferate, migrate, and invade via the MET and PI3K/AKT signaling pathways. Additionally, MET’s overexpression partially reversed the anti-OS and PI3K/AKT signaling pathways suppression effect of DDTC-Cu(I). Furthermore, the SaOS2 xenograft mice model was utilized to confirm the in-vivo anti-OS efficacy of DDTC-Cu(I) by MET protein inhibition. The histological research revealed that DDTC-Cu(I) had no adverse influence on the liver, heart, lungs, and kidneys. Overall, the data of this investigation suggested that DDTC-Cu(I) could serve as an efficient agent against OS development. |
| format | Article |
| id | doaj-art-636e2c8e8d5148c395ff20c439558aa6 |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-636e2c8e8d5148c395ff20c439558aa62025-08-20T03:45:28ZengNature PortfolioScientific Reports2045-23222025-07-0115111210.1038/s41598-025-06748-6DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathwayRuhao Zhou0Lei Yan1Kun Zhang2Song Chen3Yang Yu4Xiaochun Wei5Yongchun Pan6Chaojian Xu7Xiaojuan Sun8Zhi Lv9Pengcui Li10Xiaochen Qiao11Yi Feng12Zhi Tian13Second Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversityDepartment of Orthopedics, The Third People’s Hospital of Datong CitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversitySecond Clinical Medical College, Shanxi Medical UniversityAbstract Osteosarcoma (OS) is a frequently occurring bone malignancy with increased metastatic properties, causing deaths in large numbers around the world. Disulfiram (DSF) is clinically utilized to treat alcohol dependency and has been indicated to bind Cu(I) in-vivo to form DDTC-Cu(I), which has been confirmed for its antitumor effects. This investigation aimed to elucidate the efficacy of DDTC-Cu(I) on OS cell apoptosis, migration, growth, invasion, and underlying mechanisms. The in-vitro investigations were performed on U2OS, SaOS2, and MG-63 OS cell lines and included CCK-8, colony formation, RTCA, transwell invasion, flow cytometry, wound healing, and RNA seq assays. DDTC-Cu(I) was inoculated dose-dependent, increased apoptosis, and suppressed cells’ ability to proliferate, migrate, and invade via the MET and PI3K/AKT signaling pathways. Additionally, MET’s overexpression partially reversed the anti-OS and PI3K/AKT signaling pathways suppression effect of DDTC-Cu(I). Furthermore, the SaOS2 xenograft mice model was utilized to confirm the in-vivo anti-OS efficacy of DDTC-Cu(I) by MET protein inhibition. The histological research revealed that DDTC-Cu(I) had no adverse influence on the liver, heart, lungs, and kidneys. Overall, the data of this investigation suggested that DDTC-Cu(I) could serve as an efficient agent against OS development.https://doi.org/10.1038/s41598-025-06748-6DisulfiramDDTC-Cu(I)OsteosarcomaRNA seqMET/PI3K/Akt signaling pathway |
| spellingShingle | Ruhao Zhou Lei Yan Kun Zhang Song Chen Yang Yu Xiaochun Wei Yongchun Pan Chaojian Xu Xiaojuan Sun Zhi Lv Pengcui Li Xiaochen Qiao Yi Feng Zhi Tian DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway Scientific Reports Disulfiram DDTC-Cu(I) Osteosarcoma RNA seq MET/PI3K/Akt signaling pathway |
| title | DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway |
| title_full | DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway |
| title_fullStr | DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway |
| title_full_unstemmed | DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway |
| title_short | DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway |
| title_sort | ddtc cu i inhibits human osteosarcoma cells growth by repressing met pi3k akt signaling pathway |
| topic | Disulfiram DDTC-Cu(I) Osteosarcoma RNA seq MET/PI3K/Akt signaling pathway |
| url | https://doi.org/10.1038/s41598-025-06748-6 |
| work_keys_str_mv | AT ruhaozhou ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT leiyan ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT kunzhang ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT songchen ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT yangyu ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT xiaochunwei ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT yongchunpan ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT chaojianxu ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT xiaojuansun ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT zhilv ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT pengcuili ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT xiaochenqiao ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT yifeng ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway AT zhitian ddtccuiinhibitshumanosteosarcomacellsgrowthbyrepressingmetpi3kaktsignalingpathway |